US Bancorp DE Has $33.77 Million Position in Cigna Group $CI

US Bancorp DE cut its position in Cigna Group (NYSE:CI) by 0.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 102,155 shares of the health services provider’s stock after selling 211 shares during the period. US Bancorp DE’s holdings in Cigna Group were worth $33,771,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Family Legacy Inc. boosted its position in Cigna Group by 0.5% in the first quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider’s stock valued at $2,138,000 after buying an additional 31 shares in the last quarter. Impact Investors Inc boosted its position in Cigna Group by 1.6% in the first quarter. Impact Investors Inc now owns 1,975 shares of the health services provider’s stock valued at $650,000 after buying an additional 31 shares in the last quarter. Mission Wealth Management LP boosted its position in Cigna Group by 1.5% in the first quarter. Mission Wealth Management LP now owns 2,101 shares of the health services provider’s stock valued at $691,000 after buying an additional 32 shares in the last quarter. Westend Capital Management LLC boosted its position in Cigna Group by 8.1% in the first quarter. Westend Capital Management LLC now owns 427 shares of the health services provider’s stock valued at $140,000 after buying an additional 32 shares in the last quarter. Finally, Financial Network Wealth Advisors LLC boosted its position in Cigna Group by 26.8% in the first quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock valued at $53,000 after buying an additional 34 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have weighed in on CI. Truist Financial set a $375.00 target price on shares of Cigna Group in a research note on Tuesday, September 2nd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Cigna Group in a research note on Wednesday. Wells Fargo & Company boosted their target price on shares of Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a research note on Tuesday. Barclays boosted their target price on shares of Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Finally, TD Cowen raised shares of Cigna Group to a “strong-buy” rating in a research note on Monday, June 23rd. Two analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $372.69.

Cigna Group Trading Down 1.7%

CI opened at $301.00 on Friday. The firm’s fifty day moving average is $294.68 and its two-hundred day moving average is $309.31. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The firm has a market cap of $80.35 billion, a PE ratio of 16.43, a price-to-earnings-growth ratio of 0.90 and a beta of 0.45. Cigna Group has a twelve month low of $256.89 and a twelve month high of $358.88.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. During the same quarter in the prior year, the firm earned $6.72 earnings per share. The firm’s revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were given a $1.51 dividend. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. Cigna Group’s dividend payout ratio (DPR) is 32.97%.

Insiders Place Their Bets

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider owned 51,182 shares in the company, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This represents a 52.66% decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by company insiders.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.